» Authors » Maria Moriondo

Maria Moriondo

Explore the profile of Maria Moriondo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 791
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lastrucci V, Pacifici M, Puglia M, Alderotti G, Berti E, Bonaccorsi G, et al.
Int J Infect Dis . 2025 Mar; :107879. PMID: 40089054
Background: RSV epidemiology was disrupted by the COVID-19 pandemic. This study investigates the 2023/2024 RSV season in Tuscany, Italy, to assess trends in seasonality and incidence of RSV-associated hospitalizations compared...
2.
Syrogiannopoulos G, Michoula A, Moriondo M, Nieddu F, Syrogiannopoulou T, Anthracopoulos M, et al.
Vaccine . 2025 Mar; :126765. PMID: 40064582
Background: In Greece, pneumococcal conjugate vaccines (PCVs) became sequentially available: 7-valent in October 2004, 10-valent in May 2009, 13-valent in June 2010 and 15-valent in March 2023; soon after availability...
3.
Guarnieri V, Palmas G, Trapani S, Mollo A, Macucci C, Gambini I, et al.
Pediatr Pulmonol . 2024 Nov; 60(1):e27394. PMID: 39545630
Aim: Examine the trends and epidemiological features of acute hospitalized bronchiolitis cases among children aged 28 days to 2 years, both before and after the COVID-19 pandemic. Furthermore, evaluate their...
4.
Lastrucci V, Pacifici M, Puglia M, Alderotti G, Berti E, Riccio M, et al.
Int J Infect Dis . 2024 Nov; 149:107286. PMID: 39520876
No abstract available.
5.
Moracas C, Poeta M, Grieco F, Tamborino A, Moriondo M, Stracuzzi M, et al.
Infection . 2024 Oct; PMID: 39377906
Purpose: To compare the clinical severity of Human Adenovirus (HAdV) infection with other viral diseases in a cohort of children, evaluating presentation, therapy, and outcome. Methods: We conducted a retrospective...
6.
Lastrucci V, Pacifici M, Puglia M, Alderotti G, Berti E, Riccio M, et al.
Int J Infect Dis . 2024 Sep; 148:107231. PMID: 39222708
Objectives: To investigate seasonality, epidemiologic characteristics, and clinical severity variations of respiratory syncytial virus (RSV)-associated hospitalizations following the easing of COVID-19 restrictions in Tuscany, Italy, up to the 2022-2023 season....
7.
Guarnieri V, Macucci C, Mollo A, Trapani S, Moriondo M, Vignoli M, et al.
Vaccine . 2024 Jul; 42(21):126170. PMID: 39079812
Objective: Respiratory syncytial virus (RSV) causes significant lower respiratory tract infections (LRTIs) in infants and young children. Current prevention targets those under 2 years. This study aims to evaluate RSV...
8.
Lodi L, Catamero F, Voarino M, Barbati F, Moriondo M, Nieddu F, et al.
Front Pharmacol . 2024 Jun; 15:1381107. PMID: 38841370
Respiratory Syncytial Virus (RSV) is the primary cause of respiratory infections and hospitalizations in young children globally, leading to substantial disease burden and mortality. The aim of the present study...
9.
Bartolini L, Ricci S, Azzari C, Moriondo M, Nieddu F, LErario M, et al.
Euro Surveill . 2024 Apr; 29(17). PMID: 38666399
A severe outbreak of influenza A(H1N1pdm09) infection in seven children (median age: 52 months) occurred between December 2023 and January 2024 in Tuscany, Italy. Clinical presentation ranged from milder encephalopathy...
10.
Ricci S, Guarnieri V, Capitanini F, Pelosi C, Astorino V, Boscia S, et al.
J Allergy Clin Immunol Pract . 2024 Apr; 12(6):1622-1630.e4. PMID: 38636590
Background: Inborn errors of immunity (IEIs) include 485 inherited disorders characterized by an increased susceptibility to life-threatening infectious diseases, autoimmunity, and malignant diseases with a high mortality rate in the...